Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Squamous Cell Carcinoma of the Head and Neck – Unmet Need – Unmet Need – Squamous Cell Carcinoma of the Head and Neck (US/EU)
The angiogenesis inhibitor Erbitux, in combination with platinum-based therapy and 5-fluorouracil (5-FU), was the standard treatment option for all squamous cell carcinoma of the head and neck (…
Asthma | Treatment Algorithms: Claims Data Analysis | Pediatric Asthma | US | 2022
Pediatric asthma is treated using two types of pharmacotherapies: rescue therapy for acute symptoms via bronchodilation (e.g., a SABA such as Teva’s ProAir HFA) and maintenance therapy to prevent…
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Executive Insights – Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Executive Insights | US/EU5 | 2022
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disorder caused by inflammation and demyelination of the peripheral nerves characterized by weakness associated with loss of…
Inflammatory Myositis – Executive Insights – Inflammatory Myositis: Executive Insights | US/EU5 | 2022
Inflammatory myositis (IM) is a heterogeneous group of autoimmune disorders characterized by immune-mediated muscle injury that results in muscle inflammation and skeletal muscle weakness…
Bullous Pemphigoid – Executive Insights – Bullous Pemphigoid | Executive Insights | US/EU5 | 2022
Bullous pemphigoid (BP) is the most common type of subepidermal autoimmune bullous diseases, which characteristically affects the elderly and is seen mainly in patients older than 60. The disease…
Ulcerative Colitis | Treatment Algorithms: Claims Data Analysis | Adult | US | 2022
Ulcerative colitis (UC) is a chronic intermittent relapsing disorder of the large intestine and rectum. Treatment typically begins with conventional agents (e.g., 5-aminosalicylic acids [5-ASAs])…
Hemolytic Disease of the Fetus and Newborn – Executive Insights – Hemolytic Disease of the Fetus and Newborn | Executive Insights | US/EU5
Hemolytic disease of the fetus and newborn (HDFN), also known as alloimmune HDFN or erythroblastosis fetalis, is a rare red blood cell disorder in which maternal antibodies attack the red blood…
Fetal and Neonatal Alloimmune Thrombocytopenia – Executive Insights – Fetal and Neonatal Alloimmune Thrombocytopenia | Executive Insights | US/EU5
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare, alloimmune thrombocytopenic disorder affecting fetuses / neonates, characterized in severe cases by intracranial hemorrhage. It can…
Chronic Heart Failure | Reduced Ejection Fraction | Treatment Algorithms | Claims Data Analysis | US | 2022
Although heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all chronic heart failure cases and even though our understanding of the disease’s…
